| Bioactivity | Dagrocorat (PF-00251802) hydrochloride is an orally active and selective high-affinity partial agonist of the glucocorticoid receptor. Dagrocorat hydrochloride is also a time-dependent reversible inhibitor of CYP3A (IC50=1.3 μM in human liver microsomes) and CYP2D6 (Ki=0.57 μM in human liver microsomes). Dagrocorat hydrochloride can be used for the research of rheumatoid arthritis[1]. | ||||||||||||
| Invitro | Dagrocorat hydrochloride is metabolized by cytochrome P450 (CYP)3A to an N-oxide metabolite. Dagrocorat hydrochloride is a reversible inhibitor of several CYPs, such as CYP3A and CYP2D6[1]. | ||||||||||||
| Name | Dagrocorat hydrochloride | ||||||||||||
| CAS | 1044535-61-6 | ||||||||||||
| Formula | C29H30ClF3N2O2 | ||||||||||||
| Molar Mass | 531.01 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Ripp SL, et al. In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor. Clin Pharmacol Drug Dev. 2018;7(3):244-255. |
Dagrocorat hydrochloride
CAS: 1044535-61-6 F: C29H30ClF3N2O2 W: 531.01
Dagrocorat (PF-00251802) hydrochloride is an orally active and selective high-affinity partial agonist of the glucocorti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.